Hôpital Carémeau
Nîmes, 30000, France
NCT Number: NCT00153257
Hypothesis / aims of study A RCT has shown that results of prolapse repair via vaginal approach could be improved when a polypropylene mesh is used as tissue support (1). However, non protected heavy-weight meshes were associated with a high rate of local complications such as vaginal erosions and dyspareunia (2). The aim of this multicentre study is to evaluate anatomical and functional results of an innovative low-weight polypropylene mesh protected by an absorbable hydrophilic film in the prolapse repair by vaginal route, in comparison by the standard anterior colporrhaphy.
Study design, materials and methods This study involves 15 centres in French Private or Public Hospital. Patients will be randomly allocated to be operated by a standard anterior colporrhaphy or by an anterior repair reinforced by a specially designed mesh: UgytexTM (Sofradim, France). Ugytex is a low-weight (38g/m²) and highly porous (average porosity: 89%, pores over 1.5mm) polypropylene monofilament mesh offering tissue ingrowth and connective differentiation for a stable and long-term support. The mesh is coated with a hydrophilic film composed of atelocollagen, polyethylene glycol and glycerol. The absorbable coating protects delicate pelvic viscera from the risk of acute inflammation during the healing's inflammatory peak. Prolapse severity will be evaluated using the POP-Q system. In order to evaluate the patient's quality of life, the validated PFDI and the PFIQ questionnaires will be used preoperatively and during follow-up (3), as well as a validated questionnaire on sexual problems. The difference on one-year cure rate should be 15% (80% for the anterior colporrhaphy and 95% for the mesh repair). Then the estimated number of patient is 97 in each arm.
Looking for future studies?
Notify Me60 year and older
Female
Interventional
Not applicable
Nîmes, 30000, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Anterior repair reinforced by a specially designed mesh: UgytexTM
Time frame: 1 year
POP-Q score
Time frame: 3 years
Number of Major and minor complication
Time frame: 3 years
Symptoms and quality of life questionnaires
Time frame: 3 years
Time frame: 3 years
PISQ score
Centre Hospitalier Universitaire de Nīmes
Other
Comparison of the Prosthesis Ugytex by the Trans-obturator Approach and Anterior Colporrhaphy for the Surgical Treatment of Anterior Vaginal Wall Prolapse
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02431897
Cystocele, Female Urogenital Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04038099
Cystocele, Female Urogenital Diseases
Dallas, Texas, United States
View Trial DetailsNCT00475540
Cystocele, Digestive System Diseases
Washington D.C., District of Columbia, United States
View Trial DetailsNCT00557882
Cystocele, Female Urogenital Diseases
Washington D.C., District of Columbia, United States
View Trial Details